These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25303408)

  • 1. The synthesis of 14C-labeled N-succinimidyl-3-maleimidopropionate, a linker molecule for PEGylated biologics.
    Cao K; Maxwell BD; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2014 Oct; 57(12):667-9. PubMed ID: 25303408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).
    Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
    Bioorg Med Chem Lett; 2011 Jan; 21(1):245-9. PubMed ID: 21115250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient synthesis of biologically interesting 3,4-diaryl-substituted succinimides and maleimides: application of iron-catalyzed carbonylations.
    Prateeptongkum S; Driller KM; Jackstell R; Spannenberg A; Beller M
    Chemistry; 2010 Aug; 16(31):9606-15. PubMed ID: 20521287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
    Steffen AC; Almqvist Y; Chyan MK; Lundqvist H; Tolmachev V; Wilbur DS; Carlsson J
    Oncol Rep; 2007 May; 17(5):1141-7. PubMed ID: 17390057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeling of phosphatidylserine-binding peptides with prosthetic groups N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM) and N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB).
    Kapty J; Kniess T; Wuest F; Mercer JR
    Appl Radiat Isot; 2011 Sep; 69(9):1218-25. PubMed ID: 21571539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13.
    Hrapchak M; Latli B; Wang XJ; Lee H; Campbell S; Song JJ; Senanayake CH
    J Labelled Comp Radiopharm; 2014 Oct; 57(12):687-94. PubMed ID: 25332189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.
    Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicyclic guanidine-catalyzed direct asymmetric allylic addition of N-aryl alkylidene-succinimides.
    Wang J; Liu H; Fan Y; Yang Y; Jiang Z; Tan CH
    Chemistry; 2010 Nov; 16(42):12534-7. PubMed ID: 20865705
    [No Abstract]   [Full Text] [Related]  

  • 9. Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU).
    Marik J; Sutcliffe JL
    Appl Radiat Isot; 2007 Feb; 65(2):199-203. PubMed ID: 16935516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[(18)F]fluorobenzoate ([(18)F]SFB).
    Mäding P; Füchtner F; Wüst F
    Appl Radiat Isot; 2005 Sep; 63(3):329-32. PubMed ID: 15949940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 3H, 13C,2H3,15N and 14C-labelled SCH 466036, a histamine 3 receptor antagonist.
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; Lavey C; McNamara P; Voronin K
    J Labelled Comp Radiopharm; 2015 Feb; 58(2):36-41. PubMed ID: 25689968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of a carbon-14 labeled pegylated Adnectin™ for placental transfer studies in guinea pigs.
    Maxwell BD; Cao K; Bonacorsi S; Sivaraman L; Wang B; McNerney M; Wang L; Christopher LJ; Fung NK; Wang J; Arnold ME
    J Labelled Comp Radiopharm; 2013; 56(9-10):492-4. PubMed ID: 24285527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of carbon-14 and stable isotope labeled Avagacestat: a novel gamma secretase inhibitor for the treatment of Alzheimer's disease.
    Burrell RC; Easter JA; Cassidy MP; Gillman KW; Olson RE; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2014 Aug; 57(10):600-5. PubMed ID: 25196195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of [14C]-labeled 2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy]pyridine, a phosphodiesterase 4 inhibitor and its metabolites.
    Ochi T; Sawayama Y; Kawasaki M; Nigo T; Nakao M; Omodani T; Sumiyoshi T
    J Labelled Comp Radiopharm; 2014 Jun; 57(7):477-9. PubMed ID: 24966159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis.
    Pozzi OR; Zalutsky MR
    J Nucl Med; 2005 Aug; 46(8):1393-400. PubMed ID: 16085599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of two potent glucocorticoid receptor agonists labeled with carbon-14 and stable isotopes.
    Latli B; Reeves JT; Tan Z; Hrapchak M; Song JJ; Busacca CB; Senanayake CH
    J Labelled Comp Radiopharm; 2015; 58(11-12):445-52. PubMed ID: 26391408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB).
    Wuest F; Köhler L; Berndt M; Pietzsch J
    Amino Acids; 2009 Feb; 36(2):283-95. PubMed ID: 18414978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of isotope-labeled HSP90 inhibitor: [(13) CD3 ] and [(14) C]-TAK-459.
    Plesescu M; Elliott EL; Li Y; Prakash SR
    J Labelled Comp Radiopharm; 2014 Jul; 57(9):574-8. PubMed ID: 24992204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET.
    Höglund J; Tolmachev V; Orlova A; Lundqvist H; Sundin A
    Nucl Med Biol; 2000 Nov; 27(8):837-43. PubMed ID: 11150718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of deleobuvir, a potent hepatitis C virus polymerase inhibitor, and its major metabolites labeled with carbon-13 and carbon-14.
    Latli B; Hrapchak M; Chevliakov M; Li G; Campbell S; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2015 May; 58(6):250-60. PubMed ID: 25964148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.